Searched for
MOLECULAR DIAGNOSTICS
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Forget blood tests, your cell's sugar coat may be the earliest cancer signal we have ever foundA new study shows that over 90% of cancer cases begin with subtle cellular changes before symptoms appear. Scientists now highlight hidden ...
- In 1983, Kary Mullis imagined copying DNA while driving through California at night: the idea transformed modern genetics foreverWhile cruising through the scenic highways of California, a visionary scientist named Kary Mullis stumbled upon an extraordinary concept th...
- IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical researchIIT Roorkee has launched the Ashok Soota Molecular Medicine Facility, a state-of-the-art platform for advanced biomedical research, drug di...
- US Stock Market IPO: BillionToOne files initial public offeringBillionToOne develops molecular diagnostic tests — including a non-invasive prenatal screen and liquid biopsy — for diseases.
- Fundamental Radar: Why is Kilpest India poised to test Rs 1,184 in 12 months? Sandeep Raina explainsBrokerage firm Nuvama expects Kilpest India to sustain healthy growth in the molecular diagnostics business, led by product launches, acqui...
- Cepheid opens manufacturing site in Bengaluru to make TB testing cartridgesThe Cepheid manufacturing project was initiated in 2018 to support the Indian market. The local manufacturing of components will make Cephe...
- Synthetic biology startup D-Nome raises $1.5 million in funding from Ankur Capital, Campus FundD-Nome's focus is to build rapid point-of-care diagnostics for human infectious diseases and other applications using genomics and syntheti...
- Omicron variant to be detected in 20 minutes by molecular diagnosis testPOSTECH announced on the 10th that a research team led by Professor Lee Jung-wook of the Department of Chemical Engineering has developed m...
- Swiss pharma giant Roche to buy American firm GenMark Diagnostics for $1.8 billionRoche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10.
- India plans to double testing capacity through new project: C-CAMPThe Rockefeller Foundation has provided financial support for the project executed by the Bangalore Life Science Cluster, which would impro...
- Mylab launches machine to automate molecular diagnostic tests including those for COVID-19Earlier in March, Mylab had received commercial approval from the Central Drugs Standard Control Organisation (CDSCO) for its COVID-19 test...
- COVID-19 impact: Test-kit makers rue ‘total’ export banMolecular diagnostics companies have expressed concern after the government on Saturday decided to ban export of all diagnostic kits and re...
- At least a week to put testing kits in the market: Molecular diagnostic companiesPrivate molecular diagnostic companies have received licenses to get their tests validated but they cannot sell those kits under the curren...
- Motilal Oswal PE fund to invest up to Rs 240 crore in Molbio DiagnosticsMolbio along with its subsidiary Bigtec Labs, has developed and commercialised Truenat, which is claimed to be the world's first commercial...
- Molecular diagnostic firm Myriad Genetics partners with Positive BioscienceThese tests will help screen for cancer risks and enable families of cancer patients to take various preventive measures.
- HLL Lifecare to launch chikungunya, dengue diagonstic kitsHLL Lifecare Limited is all set to foray into molecular diagnostics area with a duplex test kit to make chikungunya and dengue fever tests ...
- Dabur OnQuest hopes to get CAP accreditation next yearDabur OncQuest, a subsidiary of Dabur pharma, is hoping to get accreditation from College of American Pathologists next year.
Load More
